SCARSELLI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 6.107
AS - Asia 3.019
EU - Europa 2.378
SA - Sud America 400
AF - Africa 196
Continente sconosciuto - Info sul continente non disponibili 162
OC - Oceania 8
Totale 12.270
Nazione #
US - Stati Uniti d'America 5.946
SG - Singapore 989
IT - Italia 973
CN - Cina 723
HK - Hong Kong 474
VN - Vietnam 424
SE - Svezia 351
BR - Brasile 335
GB - Regno Unito 242
DE - Germania 197
BG - Bulgaria 150
CA - Canada 114
CI - Costa d'Avorio 112
FR - Francia 104
TR - Turchia 98
RU - Federazione Russa 86
FI - Finlandia 71
UA - Ucraina 58
IN - India 51
JP - Giappone 47
KR - Corea 44
BD - Bangladesh 41
AR - Argentina 30
CH - Svizzera 26
BE - Belgio 23
NL - Olanda 22
MX - Messico 21
ES - Italia 20
SN - Senegal 18
IQ - Iraq 16
UZ - Uzbekistan 15
ZA - Sudafrica 15
PL - Polonia 14
ID - Indonesia 13
EG - Egitto 11
PK - Pakistan 11
IL - Israele 9
MA - Marocco 9
TN - Tunisia 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
SA - Arabia Saudita 8
AT - Austria 7
EC - Ecuador 7
GR - Grecia 7
IE - Irlanda 7
MY - Malesia 7
AU - Australia 6
CO - Colombia 6
CR - Costa Rica 6
DZ - Algeria 6
JM - Giamaica 6
JO - Giordania 5
PA - Panama 5
AL - Albania 4
KE - Kenya 4
LB - Libano 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
PS - Palestinian Territory 4
UY - Uruguay 4
AZ - Azerbaigian 3
CG - Congo 3
CZ - Repubblica Ceca 3
EE - Estonia 3
PH - Filippine 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BB - Barbados 2
BJ - Benin 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
KZ - Kazakistan 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CL - Cile 1
ET - Etiopia 1
IR - Iran 1
KG - Kirghizistan 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PR - Porto Rico 1
RO - Romania 1
SO - Somalia 1
SV - El Salvador 1
YE - Yemen 1
Totale 12.108
Città #
Ashburn 629
Singapore 561
Hong Kong 461
Fairfield 422
Santa Clara 411
San Jose 409
Dallas 359
Chandler 344
Woodbridge 301
Ann Arbor 222
Milan 201
Houston 197
Seattle 189
Shanghai 175
Beijing 157
Cambridge 155
Wilmington 154
Sofia 148
Lancaster 124
Los Angeles 123
New York 122
Serra 122
Ho Chi Minh City 119
Abidjan 112
Boardman 99
Pisa 80
Hanoi 78
Ottawa 74
Jacksonville 72
Hefei 69
Princeton 67
Lawrence 64
Council Bluffs 62
Lauterbourg 54
Frankfurt am Main 49
Izmir 49
Medford 49
Florence 47
Munich 47
Nanjing 40
Seoul 39
Rome 37
Tokyo 37
São Paulo 36
Des Moines 33
San Diego 33
Buffalo 32
Redwood City 31
London 29
Atlanta 28
Chicago 28
Istanbul 27
Da Nang 25
Redondo Beach 24
Brussels 22
Nanchang 20
Dakar 18
Nuremberg 18
Haiphong 17
Shenyang 17
Bern 16
Turku 16
Dearborn 15
Jüchen 15
Baltimore 14
Boulder 14
Dong Ket 14
Ogden 14
San Francisco 14
Tashkent 14
Bologna 13
Kunming 13
Orem 13
Washington 13
Belo Horizonte 12
Bremen 12
Helsinki 12
Brooklyn 11
Chennai 11
L'aquila 11
Rio de Janeiro 11
Turin 11
Montreal 10
Paris 10
Warsaw 10
Denver 9
Detroit 9
Fuzhou 9
Jiaxing 9
Zurich 9
Biên Hòa 8
Dhaka 8
Norwalk 8
Stockholm 8
Toronto 8
Bắc Ninh 7
Columbus 7
Düsseldorf 7
Hải Dương 7
Livorno 7
Totale 8.207
Nome #
Optimizing the Time and Dose of Melatonin as a Sleep‐Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose−Response Meta‐Analysis 380
Is Trazodone Contramid Useful in Inducing Patients to Refrain from Using Cocaine after Detoxification, so Avoiding Early Relapse? A Case Series 369
Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications 271
Dopamine D2 receptors dimers: how can we pharmacologically target them? 231
G Protein-Coupled Receptor (GPCR) Signaling Pathways in Beta-Cells 227
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism 216
Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: Methods, dynamics and biological function 203
Acetaldehyde and parkinsonism: role of CYP450 2E1. 201
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences 200
Multiple residues in the second extracellular loop are critical for M-3 muscarinic acetylcholine receptor activation 193
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib 190
Dichlorodiphenyltrichloroethane (DDT) induced extracellular vesicle formation: a potential role in organochlorine increased risk of Parkinson's disease 183
Apomorphine has a potent antiproliferative effect on Chinese hamster ovary cells 183
Is adult hippocampal neurogenesis really relevant for the treatment of psychiatric disorders? 180
Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells 179
Experimental strategies for studying g protein-coupled receptor homo- and heteromerization with radioligand binding and signal transduction methods 177
Melatonin as a Chronobiotic with Sleep-promoting Properties 175
An unusual form of the association binding kinetics of N-[ [H-3] methylscopolamine to the split muscarinic M-2trunk/M-2tail receptor 171
The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors SB269652 May Lead to a New Generation of Antipsychotic Drugs 165
A New Threat to Dopamine Neurons: The Downside of Artificial Light 164
Rapid identification of functionally critical amino acids in a G protein-coupled receptor 162
Regulation of M-3 Muscarinic Receptor Expression and Function by Transmembrane Protein 147 160
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors? 159
Variants of G protein-coupled receptors: A reappraisal of their role in receptor regulation 159
Parkinson's disease and light: The bright and the Dark sides 154
A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center 153
Neurotoxic and Neuroprotective Role of Exosomes in Parkinson's Disease 151
Mesenchymal Stem Cell in Pancreatic Islet Transplantation 147
Constitutive Internalization of G Protein-coupled Receptors and G Proteins via Clathrin-independent Endocytosis 145
Quantitative Photo Activated Localization Microscopy: Unraveling the Effects of Photoblinking RID D-6414-2011 145
Atypical antipsychotics and metabolic syndrome: From molecular mechanisms to clinical differences 143
Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3 receptors 142
Photoactivatable Fluorescent Protein mEos2 Displays Repeated Photoactivation after a Long-Lived Dark State in the Red Photoconverted Form 142
RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo 141
Pharmacological evidence of muscarinic receptor heterodimerization. 139
Potent activation of dopamine D-3/D-2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole 138
Heterodimerization of G-protein-coupled receptors reveals an unexpected level of pharmacological diversity 138
The paired activation of the two components of the muscarinic M3 receptor dimer is required for induction of ERK1/2 phosphorylation 138
Therapeutic association of caffeine and 5-hydroxy-tryptophan (5-HTP) for the treatment of the symptoms of Parkinson’s disease such as daytime sleepiness and the nodding-off induced by dopamine mimetics 137
A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center 136
Historical Perspectives: From Monomers to Dimers and Beyond, an Exciting Journey in the World of G Protein-Coupled Receptors 136
Dopamine agonists and analogues have and antiproliferative effect on chinese hamster ovary cells 135
Apomorphine, dopamine and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate 1 134
Identification of clustering artifacts in photoactivated localization microscopy RID D-6414-2011 RID C-5350-2011 133
D2/D3 dopamine receptor heterodimers exhibit unique functional properties 133
Heterodimerization of G-protein-coupled receptors reveals an unexpected level of pharmacological diversity 128
Challenges in quantitative single molecule localization microscopy. 128
Cell Type-specific beta 2-Adrenergic Receptor Clusters Identified Using Photoactivated Localization Microscopy Are Not Lipid Raft Related, but Depend on Actin Cytoskeleton Integrity 126
Functional rescue of the inactive splice variant of the dopamine D3 receptor D3(nf) 125
Identification of the factors affecting co-localization precision for quantitative multicolor localization microscopy 123
Progress in quantitative single-molecule localization microscopy. 122
Dichlorodiphenyltrichloroethane, an old pesticide with a new mechanism of toxicity 121
Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In Vivo 119
Enlightening G-protein-coupled receptors on the plasma membrane using super-resolution photoactivated localization microscopy. 114
The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology 111
Modulation of dopamine D₁ receptors via histamine H₃ receptors is a novel therapeutic target for huntington’s disease 111
Apomorphine - A novel effect for an old compound 107
A chemical-genetic approach to study G protein regulation of beta cell function in vivo 105
Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson’s Disease 104
Dopamine-mediated autocrine inhibition of insulin secretion 104
Pharmacological evidence of muscarinic receptor heterodimerization 104
Influence of substance use disorder on treatment retention of adult-attention-deficit/hyperactive disorder patients. A 5-year follow-up study 104
Determination of G-protein–coupled receptor oligomerization by molecular brightness analyses in single cells 103
Long-term Efficacy and Safety of Sodium Oxybate in Treating Alcohol Use Disorder: A Systematic Review and Meta-Analysis 101
Therapeutic Drug Monitoring in Neuropsychiatric Disorders 101
Identification of a novel protein partner of the M3 muscarinic acetylcholine receptor 100
Symptomatological variants and related clinical features in adult attention deficit hyperactive disorder 100
Allosteric modulators of g protein-coupled dopamine and serotonin receptors: A new class of atypical antipsychotics 97
Exogenous Melatonin as a Sleep-promoting Agent beyond its ChronobioticProperties: A Scoping Review of its Effects on Key Sleep-wakeNeurotransmitters 95
Atypical Antipsychotics 91
Triple Diagnosis of Attention-Deficit/Hyperactivity Disorder with Coexisting Bipolar and Alcohol Use Disorders: Clinical Aspects and Pharmacological Treatments 89
Methadone dose escalation in patients with opioid use disorder and cancer as a strategy for controlling cancer-related pain: A case series 89
Lithium and Valproic Acid in Bipolar Disorders and Beyond 88
β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP+) and 6-Hydroxydopamine (6-OHDA) 88
null 87
Subjectively reported sleep improvement with antipsychotic medications in clinical practice: A systematic review, meta-analysis and meta-regression of moderating factors 86
Interaction of the preferential D3 agonist (+)PHNO with dopamine D3-D2 receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imaging 85
Reconstitution of functional dopamine D(2s) receptor by co-expresssion of amino- and carboxyl-terminal receptor fragments 76
Pharmacokinetics and Monitoring of Methotrexate in Adults with Acute Lymphoblastic Leukaemia: A 10-Year Follow-Up at an Italian Centre 73
GPCRs in Intracellular Compartments: New Targets for Drug Discovery 72
null 71
Synergistic combination of the adrenergic antagonist SR59230A with common chemotherapeutic drugs and target therapies in cancer and endothelial cells 68
null 68
null 67
In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic Neurons 64
Integration and spatial organization of signaling by g protein-coupled receptor homo-and heterodimers 63
Methylphenidate for the Treatment of Cocaine Use Disorder: A Systematic Review and Meta-analysis 61
Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds 60
The atypical antipsychotic clozapine selectively inhibits interleukin 8 (IL-8)-induced neutrophil chemotaxis 59
Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulation 55
Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes 55
Atypical Antipsychotics 41
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics 38
The C-terminus of the prototypical M2 muscarinic receptor localizes to the mitochondria and regulates cell respiration under stress conditions 38
Unraveling the Functional Significance of Unstructured Regions in G Protein-Coupled Receptors 27
Totale 12.270
Categoria #
all - tutte 41.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022725 0 46 21 33 102 116 38 44 39 42 65 179
2022/20231.058 135 120 76 88 98 140 3 73 263 6 42 14
2023/2024813 72 74 115 65 125 126 43 30 9 29 36 89
2024/20252.350 21 82 24 123 275 269 286 75 187 313 232 463
2025/20263.555 201 357 349 261 373 287 662 179 227 361 135 163
2026/2027643 391 252 0 0 0 0 0 0 0 0 0 0
Totale 12.270